2013. Early Virological Response of the First Line Combination Therapy (Pegylated Interferon I-2a and Ribavirin) in Iraqi Chronic Hepatitis C Patients and Their Psychological Adverse Effects. Global Journal of Medical Research. 12, 11 (Jan. 2013), 35–46.